ArticleScientific reports2020

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.

Divya P Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.